Feb 29 |
Karyopharm Therapeutics Inc. 2023 Q4 - Results - Earnings Call Presentation
|
Feb 29 |
Karyopharm Therapeutics (KPTI) Reports Q4 Loss, Tops Revenue Estimates
|
Feb 29 |
Karyopharm Therapeutics GAAP EPS of -$0.36 misses by $0.07, revenue of $33.7M beats by $0.08M
|
Feb 29 |
Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
|
Feb 29 |
Earnings Scheduled For February 29, 2024
|
Feb 28 |
Karyopharm Therapeutics Q4 2023 Earnings Preview
|
Feb 22 |
Karyopharm to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
|
Feb 19 |
Xencor (XNCR) Surges 13.4%: Is This an Indication of Further Gains?
|
Feb 15 |
Ardelyx (ARDX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
Feb 14 |
Will Karyopharm Therapeutics (KPTI) Report Negative Q4 Earnings? What You Should Know
|